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Abstract 
 
A big debate is still dividing the scientific community about detrimental or 
beneficial effects of Static Magnetic Fields (SMFs) exposure on living matter. The 
heterogeneous findings are depending on the different experimental set up used, 
i.e., magnetic induction from 10-7 to more than 10 T, homogenous or 
inhomogeneous field, time of exposure and on the biological samples, i.e., from in 
vitro cultured cells to living organisms. In spite of the amount of publications 
providing medical evidence for the beneficial effects of SMF exposure can exert on 
living matter, a researcher must kept his obligatory scepticism due to the 
difficulties comparing different measurements, to the commercial interests and to 
poor scientific rigor. Nevertheless, their use has gained wide community 
acceptance for pain relief but not for more serious diseases, such as cancer. In this 
mini-review we will discuss on the studies on the therapeutic use of moderate 
magnetic induction SMFs, focusing on those produced by permanent magnets. 
 
 
Introduction 
The effect of SMF exposure on living tissues is 
namely like sport. Few have adequate 
knowledge about it, while many have opinion 
or prejudice. It is also not widely 
acknowledged that in the past 60 years, 
parallel with the discovery and development 
of Nuclear Magnetic Resonance Spectroscopy 
(NMRS) and its entry to medical diagnosis (as 
Magnetic Resonance Imaging or MRI), serious 
research has been done resulting in 7 Nobel 
Prize winners. 
Permanent magnet therapy is classified by 
the US National Institutes of Health Centre 
for Complementary and Alternative Medicine 
under the item ‘Methodology #3-Energy’ [1]. 
Various products containing magnets, like 
shoe insoles, bracelets and other jewellery, 
mattress pads, bandages, etc., are often 
marketed for many different types of pain. 
However, the answer to laypeople as well as 
professionals to the real ‘functioning’ of 
these magnetic devices is still “we don’t 
know. They may be”. Indeed some 
arrangements, structures of permanent 
magnets exert measurable (patho) 
physiological effects when living tissues are 
exposed to them. Scientific evidences about 
the use of magnets for pain relief have had 
contradictory results. For example, it has 
been found in in vivo studies on animals that 
the exposure to an Extremely Low 
Frequency-Pulsed Magnetic Field (ELF-PMF) 
(magnetic induction comparable with a 
moderate SMF), could positively affect 
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oxidative stress parameters (e.g., Reactive 
Oxygen Species (ROS) generation) in heart, 
plasma [2-3], brain [4] and skeletal muscle 
[5]. Conversely, studies of SMF therapy for 
treatment of insomnia [6], different types of 
neuromuscoskeletal pain (e.g., knee, hip, 
wrist, foot, back, and pelvic pain) [7], 
diabetes [8], allergic inflammation [9], 
osteogenesis [10], erosive gastritis [11] and 
other diseases, suggested a benefit from 
using magnets. Interestingly, after the first 
finding of Yakovleva et al. in 1995 [12] that 
suggested the ELF magnetotherapy to treat 
breast cancer, other studies have supported 
its effectiveness, as an adjuvant factor, for 
the treatment of urogenital tumors [13-14]. 
Unfortunately, to date the efficacy of SMFs, 
generated by permanent magnets, in the 
treatment of cancer has not been 
ascertained. Permanent magnets certainly 
‘act’ at the psychosomatic level. The placebo 
effect itself has a good reputation and an 
evidence-based foundation in medicine. 
 
Current research and unresolved 
issues 
An even increasing annual number of reports 
about evidence-based medical research from 
that living objects respond to external MFs in 
a wide range of frequencies is published. 
However, as reported in the Research 
Agenda for Static Fields of the WHO (2006) 
“For SMFs, research carried out to date has 
not been systematic and has often been 
performed without appropriate methodology 
and exposure information. Coordinated 
research programs are recommended as an 
aid to a more systematic approach. There is a 
need to investigate the importance of 
physical parameters such as field intensity, 
exposure duration and field gradient on 
biological outcome.” Again, in another 
citation issued by Scientific Committee on 
Emerging and Newly Identified Health Risks 
of the EU from 2009, in the Health Effects of 
ElectroMagnetic Field (EMF) Exposure, 
“Although a fair number of studies have been 
published since the last opinion, the 
conclusion drawn there stands: there is still a 
lack of adequate data for a proper risk 
assessment of SMFs. More research is 
necessary, especially to clarify the many 
mixed and sometimes contradictory results. 
Short term effects have been observed 
primarily on sensory functions for acute 
exposure. However, there is no consistent 
evidence for sustained adverse health effects 
from short term exposure up to several 
Teslas”. The official statement of WHO and 
the EU in effect says that up to a magnetic 
induction of 8 T, the human body will not be 
jeopardized by an external SMF. 
After the early reports that were only simple 
phenomenological observations and 
descriptions, current research is still focusing 
on the mechanism(s) of action, although the 
elective site of action of SMF seems to be the 
plasma membrane [15-17]. In our research, 
we have succeeded in getting a little beyond 
the level of phenomenology by revealing 
some of the possible background 
mechanisms in action. It seems obvious today 
that a living object that has self-motion in an 
external SMF is subject to an induced time-
dependent magnetic flux and, consequently, 
to internal electric potential differences; 
however, the point whether these changes 
can be scientifically measured in the 
biological response is still open for 
discussion. By now, it is widely accepted that 
SMFs can achieve well defined observable 
bioeffects under a broad range of 
experimental and clinical physiological and 
pathological conditions [18-22]. The plethora 
of the results are also suggesting that there 
are some forms of dose-responsiveness 
related to SMFs produced by permanent 
magnets, which depend on their magnetic 
induction, polarity and application time [7]. 
Thus, from the point of view of the 
experimental model chosen, some kinds of 
SMF are more suitable than others. We 
recently studied the effects of 
inhomogeneous SMF (ranged between 200.6 
and 212.9 mT) on the molecular mediators of 
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inflammation in monocyte-derived 
macrophages [23] and on the effects of 
inhomogeneous SMF (ranged between 31.7 
and 232.0 mT) on the efficacy of cisplatin 
(cisPt) treatment on neuroblastoma SH-SY5Y 
cells [24]. Our results demonstrated that SMF 
exposure: (i) induced  release of the anti-
inflammatory cytokine IL-10 and the 
suppression of the pro-inflammatory 
cytokines IL-6, IL-8, TNF-α; (ii) was able to 
prevent cisPt cytotoxicity. These data suggest 
that the exposure to inhomogeneous SMFs of 
moderate intensity could be used for the 
treatment of inflammatory diseases and in 
the prevention/reduction of the side effects 
of cisPt-based chemotherapy. 
What role can SMF exposure have in 
therapy? In order to legitimate definitively 
the use of magnets as a substitute or support 
element of pharmacological methods, many 
controversies have to be addressed. For 
example, it is not yet clear if SMFs play an 
effective role in the management of pain, 
due to the lack of systematic research and for 
the poorness of many studies (small number 
of participants, time of investigation too 
short and inadequate controls). In addition, 
one of the main factors complicating 
interpretation of results is that there are 
many ‘dosing’ and application variables to 
consider when applying magnetic therapy, 
e.g., polarity, field strength, penetration, and 
perhaps configuration of field patterns. Thus, 
the majority of rigorous trials have found no 
effect on pain [7]. In addition, even if 
magnets are generally considered safe when 
applied to the skin, they may not be safe for 
some people because may interfere with the 
devices, such as pacemakers and implantable 
cardioverter-defibrillators or insulin pumps 
[25-28].  
 
Future perspectives and conclusion 
Some of the above discussed researches, 
ours included, are encouraging a medical use 
of permanent magnets. In all honesty, we 
must admit that not all experiments provided 
evidence for the beneficial effect of SMF 
exposure on the specific biological response 
tested. Even if a positive response was found, 
it was not always convincing that it was the 
exclusive action of SMF exposure. Therefore, 
we had to differentiate between several 
options to the best of our knowledge, 
keeping in mind that further researches are 
mandatory to identify the mechanisms and 
clinical outcomes of SMFs exposure. Thus the 
concerns that probably every researcher 
must deal with are:  
(i) Is there really no effect that can be 
measured? 
(ii) Would there be an effect if we chose a 
more appropriate model? 
(iii) Can we still miss observability of an effect 
in a perfect model by superficial execution? 
 
The better optimization of factors such as 
exposure time, polarity and field strength of 
the magnet will, for sure, improve the quality 
of results. In fact, the study of pain 
performed in animal or experimental models 
will allow to define the role of all above 
mentioned factors and determine the 
efficacy before continuing with expensive 
clinical research in patient populations [7]. In 
addition, the inclusion of raw data in specific 
databases might help to make an easy cross 
link of results. This scientific approach will 
clarify whether SMF can be used as useful 
therapeutic tool, alone or complementary to 
drugs, made them exploitable for clinicians of 
third millennium. 
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